Skip to main navigation Skip to search Skip to main content

Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology

Marco Metra, Daniela Tomasoni, Marianna Adamo*, Antoni Bayes-Genis, Gerasimos Filippatos, Magdy Abdelhamid, Stamatis Adamopoulos, Stefan D Anker, Laura Antohi, Michael Böhm, Frieder Braunschweig, Tuvia Ben Gal, Javed Butler, John G F Cleland, Alain Cohen-Solal, Kevin Damman, Finn Gustafsson, Loreena Hill, Ewa A Jankowska, Mitja LainscakLars H Lund, Theresa McDonagh, Alexandre Mebazaa, Brenda Moura, Wilfried Mullens, Massimo Piepoli, Piotr Ponikowski, Amina Rakisheva, Arsen Ristic, Gianluigi Savarese, Petar Seferovic, Rajan Sharma, Carlo Gabriele Tocchetti, Mehmet Birhan Yılmaz, Cristiana Vitale, Maurizio Volterrani, Stephan von Haehling, Ovidiu Chioncel, Andrew J S Coats, Giuseppe Rosano

*Corresponding author for this work
169 Citations (Scopus)

Abstract

Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice.

Original languageEnglish
JournalEuropean Journal of Heart Failure
Volume25
Issue number6
Pages (from-to)776-791
Number of pages16
ISSN1388-9842
DOIs
Publication statusPublished - Jun 2023

Keywords

  • Adrenergic beta-Antagonists/therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors/therapeutic use
  • Cardiology
  • Chronic Disease
  • Diuretics/therapeutic use
  • Heart Failure/epidemiology
  • Hospitalization
  • Humans
  • Quality of Life
  • Intensification of oral therapy
  • Prognosis
  • Worsening heart failure
  • Outpatients
  • Emergency department visits

Fingerprint

Dive into the research topics of 'Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology'. Together they form a unique fingerprint.

Cite this